New Criteria for Accessory Pathway Localization From Surface ECG

Overview

study for discovering new criteria for localization of site of accessory pathway from surface ECG

Full Title of Study: “Studying New Criteria for Prediction of Site of Accessory Pathway From Surface ECG”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: April 2021

Detailed Description

the study aims for discovering new criteria for percise localization of accessory pathway from surface ECG in referance to final flouroscopic ablation site

Clinical Trial Outcome Measures

Primary Measures

  • percise localization of accessory pathway from surface ECG in referance to successful ablation site
    • Time Frame: 2 years
    • successful localization of accessory pathway from surface ECG in referance to successful ablation site during EP maping

Participating in This Clinical Trial

Inclusion Criteria

  • any patient with manifest accessory pathway . Exclusion Criteria:

  • multiple accessory pathways .previous ablation.

Gender Eligibility: All

Minimum Age: 10 Years

Maximum Age: 90 Years

Investigator Details

  • Lead Sponsor
    • Assiut University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Haidy Yacoup Daoud Danial, principle investigator – Assiut University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.